Middle Escalation (Weeks 912) 6 mg (4 doses) Continued protocol consistency with improved stabilization as adaptation occurs
The front desk was not knowledgable about the requirements needed to go forward with the appointment and the nurse required me to go to my doctor for forms to be sent or spend an additional $100 for administrative costs
ClinicalTrials.gov: NCT04881760 (Phase 2, Obesity), NCT04867785 (Phase 2, T2D) Questions to ask your doctor Given my health history, is a GLP-1 medication appropriate for me at all
7 Safety considerations and patient selection GLP-1 receptor agonists have a well-defined safety profile
Proc Natl Acad Sci U S A (1990) 87(18):72604.10.1073/pnas.87.18.7260 Summary Keywords glucagon-like peptide-1, osteogenesis, bone resorption, osteoporosis, diabetes mellitus Citation Zhao C, Liang J, Yang Y, Yu M and Qu X (2017) The Impact of Glucagon-Like Peptide-1 on Bone Metabolism and Its Possible Mechanisms
Another medication in the works is dapiglutide, a blend of GLP-1 and GLP-2 agonists, and there are more therapies coming down the pike